Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shanghai ZJ Bio-Tech CoSHSE:688317 -3.47%57 Shiller PE Ratio is 11.92 as of Aug. 20, 2026, which is 4% below its 10-year median of 12.45. GuruFocus rates SHSE:688317 with a GF Score™ of 57/100 and a GF Value™ of ¥9.66 (Significantly Overvalued). The stock has 2 warning signs investors should review. Among 311 Medical Devices & Instruments companies, Shanghai ZJ Bio-Tech Co ranks better than 83.28% on this metric.
The historical rank and industry rank for Shanghai ZJ Bio-Tech Co's Shiller PE Ratio or its related term are showing as below:
SHSE:688317'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 9 Med: 12.45 Max: 19.49
Current: 11.92
During the past 13 years, Shanghai ZJ Bio-Tech Co's highest Shiller PE Ratio was 19.49. The lowest was 9.00. And the median was 12.45.
SHSE:688317's Shiller PE Ratio is ranked better than 83.28% of 311
companies
in the Medical Devices & Instruments industry
Industry Median: 27.1
vs SHSE:688317: 11.92
E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.
Shanghai ZJ Bio-Tech Co's adjusted earnings per share data of for the fiscal year that ended in Dec25 was ¥-0.190. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥1.47 for the trailing ten years ended in Dec25.
Shiller PE for Stocks: The True Measure of Stock Valuation
Shanghai ZJ Bio-Tech Co (SHSE:688317) Shiller PE Ratio Explanation
Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.
If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.
Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.
Be Aware
Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.
Shanghai ZJ Bio-Tech Co Shiller PE Ratio Related Terms
Shanghai ZJ Bio-Tech Co Shiller PE Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688317 vs ABT, SYK, MDT: Shiller PE Ratio Comparison
For the Medical Devices subindustry, Shanghai ZJ Bio-Tech Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai ZJ Bio-Tech Co Shiller PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shanghai ZJ Bio-Tech Co's Shiller PE Ratio distribution charts can be found below:
* The bar in red indicates where Shanghai ZJ Bio-Tech Co's Shiller PE Ratio falls into.
Shanghai ZJ Bio-Tech Co Shiller PE Ratio Calculation
For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.
The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Add all the adjusted EPS together and divide 10 will get our E10.
Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.
Shanghai ZJ Bio-Tech Co (SHSE:688317) has a Shiller PE Ratio of 11.92 as of Aug. 20, 2026. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. This is near median its historical median of 12.45. Over the past decade, Shanghai ZJ Bio-Tech Co's Shiller PE Ratio has ranged from 9.00 to 19.49. According to the industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #52 out of 311 companies in the Medical Devices & Instruments industry, placing it in the top 16.7%.
Is Shanghai ZJ Bio-Tech Co's Shiller PE Ratio too high?
Shanghai ZJ Bio-Tech Co's current Shiller PE Ratio of 11.92 is near median its 10-year median of 12.45. Over the past 10 years, this metric has ranged from a low of 9.00 to a high of 19.49. The Medical Devices & Instruments industry median Shiller PE Ratio is 27.10. Shanghai ZJ Bio-Tech Co's value of 11.92 is 56% below this industry median. Based on the distribution chart, Shanghai ZJ Bio-Tech Co ranks #52 out of 311 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shanghai ZJ Bio-Tech Co has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shanghai ZJ Bio-Tech Co's Shiller PE Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Shanghai ZJ Bio-Tech Co ranks #52 out of 311 companies for Shiller PE Ratio. This places Shanghai ZJ Bio-Tech Co in the top 17% of its industry — outperforming the majority of peers. The industry median Shiller PE Ratio is 27.10. Shanghai ZJ Bio-Tech Co's value of 11.92 is 56% below this benchmark. Historically, Shanghai ZJ Bio-Tech Co's own Shiller PE Ratio has ranged from 9.00 to 19.49 over the past decade. While the company's 10-year median is 12.45 vs. the industry median of 27.10, Shanghai ZJ Bio-Tech Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shiller PE Ratio for a Medical Devices & Instruments company?
The median Shiller PE Ratio among Medical Devices & Instruments companies is 27.10, based on 311 companies in the industry. Companies in the top quartile (top 25%) have a Shiller PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Shiller PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai ZJ Bio-Tech Co's current Shiller PE Ratio of 11.92 is 56% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shiller PE Ratio mean?
A high Shiller PE Ratio can signal that a stock is expensive relative to its fundamentals. Shiller price-earnings ratio is the ratio of share price to a company's inflation-adjusted earnings over a 10-year period. View historical data on Shanghai ZJ Bio-Tech Co and its competitors. For the Medical Devices & Instruments industry, the median Shiller PE Ratio is 27.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai ZJ Bio-Tech Co's current Shiller PE Ratio is 11.92, which is near median its own 10-year median of 12.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai ZJ Bio-Tech Co stock overvalued right now?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co (SHSE:688317) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥9.66, compared to a current price of ¥17.52 — trading 81.4% above its estimated fair value. The current Shiller PE Ratio is 11.92, which is near median its 10-year median of 12.45 and 56% below the Medical Devices & Instruments industry median of 27.10. Shanghai ZJ Bio-Tech Co's overall GF Score™ is 57/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shiller PE Ratio calculated?
Shiller PE Ratio is calculated from a company's financial statements. For Shanghai ZJ Bio-Tech Co (SHSE:688317), the current Shiller PE Ratio is 11.92 as of Aug. 20, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai ZJ Bio-Tech Co (SHSE:688317) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai ZJ Bio-Tech Co stock appears to be overvalued.
The current stock price of ¥17.52 is trading 81.4% above its estimated GF Value™ of ¥9.66.
GuruFocus considers Shanghai ZJ Bio-Tech Co to be Significantly Overvalued.
Key valuation signals for SHSE:688317:
Shiller PE Ratio: 11.92 (near median its 10-year median of 12.45)
GF Value™: ¥9.66 vs. price of ¥17.52 (81.4% above fair value)
Industry Position: 56% below the Medical Devices & Instruments median (#52 of 311)
No single metric tells the full story. See the SHSE:688317 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai ZJ Bio-Tech Co Ltd is engaged in research and development, production and sales of genetic diagnostic reagents and instruments and equipment. The rapid real-time fluorescent PCR diagnostic test reagents developed by the company are mainly used in clinical medicine, public health emergencies, entry-exit inspection and quarantine, food inspection, animal husbandry, aquaculture and other fields.
57GF Score
Get the complete analysis for SHSE:688317
Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688317 has been successfully added to your 
